https://gexval.com/zh-tw/info-tw/bio-tech-2018-%e5%8f%83%e5%b1%95%e5%a0%b1%e5%91%8a/2024-12-20T17:18:07+09:00https://gexval.com/zh-tw/info-tw/%e6%9c%ac%e5%85%ac%e5%8f%b8%e7%8d%b2%e9%81%b8%e7%82%ba%e7%b6%93%e6%bf%9f%e7%94%a2%e6%a5%ad%e7%b6%93%e6%bf%9f%e7%9c%812018%e5%b9%b4%e5%ba%a6%e5%9c%b0%e5%8d%80%e9%aa%a8%e5%b9%b9%e4%bc%81/2024-12-20T17:20:15+09:00https://gexval.com/zh-tw/info-tw/%e6%9c%ac%e5%85%ac%e5%8f%b8%e7%8d%b2%e9%81%b8%e7%82%ba%e7%b6%93%e6%bf%9f%e7%94%a2%e6%a5%ad%e7%b6%93%e6%bf%9f%e7%9c%812018%e5%b9%b4%e5%ba%a6%e5%9c%b0%e5%8d%80%e9%aa%a8%e5%b9%b9%e4%bc%81-2/2024-12-20T17:19:34+09:00https://gexval.com/zh-tw/info-tw/2018%e5%b9%b4%e6%97%a5%e6%9c%ac%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e5%89%b5%e6%a5%ad%e5%85%ac%e5%8f%b8%e5%b3%b0%e4%bc%9a%e5%8f%83%e5%b1%95%e9%80%9a%e7%9f%a5/2024-12-20T17:18:58+09:00https://gexval.com/zh-tw/info-tw/gexval%e5%b0%87%e5%8f%83%e5%8a%a06%e6%9c%8814%e6%97%a5%e8%87%b318%e6%97%a5%e8%88%89%e8%be%a6%e7%9a%84bio-digital/2022-09-25T00:53:37+09:00https://gexval.com/zh-tw/info-tw/gexval%e5%b0%87%e5%8f%83%e5%8a%a08%e6%9c%8825%e6%97%a5%e8%87%b327%e6%97%a5%e8%88%89%e8%be%a6%e7%9a%84chinabio-partnering-forum/2024-12-20T16:59:23+09:00https://gexval.com/zh-tw/info-tw/gexval%e5%b0%87%e5%8f%83%e5%8a%a08%e6%9c%8825%e6%97%a5%e8%87%b327%e6%97%a5%e8%88%89%e8%be%a6%e7%9a%84chinabio-partnering-forum-2/2022-09-25T00:51:35+09:00https://gexval.com/zh-tw/info-tw/gexval%e5%b0%87%e5%8f%83%e5%8a%a06%e6%9c%886%e6%97%a5%e8%87%b312%e6%97%a5%e8%88%89%e8%be%a6%e7%9a%84bio-digital/2024-05-30T13:36:12+09:00https://gexval.com/zh-tw/info-tw/gexval%e5%b0%87%e5%8f%83%e5%8a%a05%e6%9c%884%e6%97%a5%e8%87%b36%e6%97%a5%e8%88%89%e8%be%a6%e7%9a%84covid-19-virtual-partnering/2022-09-25T00:48:55+09:00https://gexval.com/zh-tw/info-tw/gexval-%e8%a2%ab%e5%88%97%e5%85%a5nikkei-biotechnology-and-business%e7%99%bc%e5%b8%83%e7%9a%84-2019-2020-%e5%b9%b4%e6%97%a5%e6%9c%ac%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e5%88%9d%e5%89%b5%e4%bc%81-2/2024-12-20T17:07:23+09:00https://gexval.com/zh-tw/info-tw/gexval-%e8%a2%ab%e5%88%97%e5%85%a5nikkei-biotechnology-and-business%e7%99%bc%e5%b8%83%e7%9a%84-2021-2022-%e5%b9%b4%e6%97%a5%e6%9c%ac%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e5%88%9d%e5%89%b5%e4%bc%81/2022-09-25T00:47:51+09:00https://gexval.com/zh-tw/ir-tw/%e5%af%a6%e6%96%bd%e7%ac%ac%e4%b8%89%e8%80%85%e9%85%8d%e9%a1%8d%e5%a2%9e%e8%b3%87/2022-09-25T00:46:18+09:00https://gexval.com/zh-tw/info-tw/gexval-%e7%99%bc%e8%a1%a8%e6%96%bc-nikkei-biotech-online/2022-09-25T00:43:48+09:00https://gexval.com/zh-tw/info-tw/dr-juan-kato-was-invited-as-a-guest-speaker-at-the-webinar-hosted-by-ctc/2024-12-20T17:02:33+09:00https://gexval.com/zh-tw/ir-tw/gexval-inc-allocates-new-shares-in-a-seed-funding-round-2/2024-05-23T12:21:53+09:00https://gexval.com/zh-tw/info-tw/gexval-participated-in-bio-europe-2018-2/2024-12-20T17:18:02+09:00https://gexval.com/zh-tw/info-tw/gexval-ceo-kato-speaks-in-san-diego-trade-mission-panel-discussion-2/2024-12-20T17:14:37+09:00https://gexval.com/zh-tw/info-tw/gexval-gives-presentation-at-bio-asia-2019/2024-12-20T17:14:37+09:00https://gexval.com/zh-tw/info-tw/gexval-participated-in-the-139th-annual-meeting-of-the-pharmaceutical-society-of-japan/2024-12-20T17:14:44+09:00https://gexval.com/zh-tw/info-tw/gexval-appeared-in-nikkei-japans-largest-financial-paper/2024-05-30T13:21:25+09:00https://gexval.com/zh-tw/info-tw/gexval-participates-in-chinabio-partnering-forum-2019/2024-12-20T17:14:07+09:00https://gexval.com/zh-tw/info-tw/gexval-participates-in-venture-innovation-pavilion/2024-12-20T17:07:13+09:00https://gexval.com/zh-tw/info-tw/scrip-interviews-gexval-focuses-on-rare-diseases-as-it-builds-on-ex-takeda-assets-2/2024-06-06T16:26:13+09:00https://gexval.com/zh-tw/info-tw/gexval-mentioned-in-nikkan-kogyo-shimbun-2/2024-12-20T17:14:43+09:00https://gexval.com/zh-tw/info-tw/gexval-featured-in-nikkan-kogyo-shimbun-2/2024-05-30T13:26:26+09:00https://gexval.com/zh-tw/info-tw/gexval-featured-in-nikkan-kogyo-shimbun-3/2024-05-30T13:27:09+09:00https://gexval.com/zh-tw/info-tw/article-by-gexval-ceo-published-in-medical-science-digest/2024-05-30T13:27:58+09:00https://gexval.com/zh-tw/info-tw/gexval-featured-in-kanagawa-shimbun-2/2024-12-20T17:02:38+09:00https://gexval.com/zh-tw/info-tw/dr-juran-kato-attended-the-lesi-htbc-asia-2/2024-12-20T17:00:23+09:00https://gexval.com/zh-tw/info-tw/dr-juran-kato-was-invited-as-a-panelist-at-lesi-annual-conference/2024-12-20T17:00:15+09:00https://gexval.com/zh-tw/info-tw/presentation-at-independents-club-business-plan-meeting-2/2024-12-20T17:00:36+09:00https://gexval.com/zh-tw/info-tw/gexval-won-the-suzhou-startup-contest-japan-tournament-2/2024-12-20T17:00:36+09:00https://gexval.com/zh-tw/info-tw/presentation-at-special-session-women-entrepreneurs-leading-a-new-era-of-independents-club-2/2024-12-20T16:46:26+09:00https://gexval.com/zh-tw/info-tw/an-article-of-an-interview-with-the-attorney-samejima-is-published-in-the-journal-the-independents-2/2024-05-29T17:03:28+09:00https://gexval.com/zh-tw/info-tw/lecture-at-the-94th-annual-meeting-of-the-japanese-biochemical-society-2/2024-10-23T15:16:49+09:00https://gexval.com/zh-tw/info-tw/lecture-by-ceo-dr-kato-in-introduction-diseases-and-drugs-class-in-kyoto-sangyo-university-2/2024-12-20T16:55:41+09:00https://gexval.com/zh-tw/ir-tw/gexval-increases-capital-of-its-australian-subsidiary-2/2024-05-30T16:26:26+09:00https://gexval.com/zh-tw/info-tw/gexval-ceo-speaks-at-cphi-japan-2024-3/2024-12-20T16:37:51+09:00https://gexval.com/zh-tw/ir-tw/gexval-completed-the-close-of-new-funding-round-with-jpy-450-million-usd-3-million-3/2024-06-03T15:19:41+09:00https://gexval.com/zh-tw/info-tw/gexval-is-listed-in-jetro-japan-startup-market-map-3/2024-06-03T15:43:20+09:00https://gexval.com/zh-tw/rd-tw/gexval-inc-announces-collaboration-with-fraxa-dvi-3/2024-06-03T16:03:01+09:00https://gexval.com/zh-tw/rd-tw/phase-1-study-of-gxv-001-in-australia-start-of-repeated-dose-study-3/2024-06-03T16:13:37+09:00https://gexval.com/zh-tw/rd-tw/hrec-approval-of-the-initiation-of-phase-1-study-of-gxv-001-in-australia-2/2024-06-04T16:05:27+09:00https://gexval.com/zh-tw/rd-tw/initiation-of-basic-research-for-drug-repurposing-utilizing-fugaku-3/2024-06-04T16:19:18+09:00https://gexval.com/zh-tw/rd-tw/successfully-completed-phase-i-single-dose-study-for-gxv-001-3/2024-06-04T16:29:15+09:00https://gexval.com/zh-tw/info-tw/gexval-ceo-won-a-prize-outstanding-leadership-awards-at-health2-0-conference-2/2024-12-20T16:44:14+09:00https://gexval.com/zh-tw/info-tw/presentation-in-new-years-social-event-of-independence-club-2/2024-12-20T16:43:17+09:00https://gexval.com/zh-tw/rd-tw/gexval-completes-phase-i-clinical-trial-of-gxv-001-in-australia-3/2024-07-16T15:46:55+09:00https://gexval.com/zh-tw/ir-tw/gexval-completes-additional-funding-of-jpy-110-million-in-series-c-extension-round-3/2024-07-17T10:02:35+09:00https://gexval.com/zh-tw/info-tw/gexval-to-present-at-bio-asia-taiwan-2024-investment-summit-3/2024-12-20T16:39:21+09:00https://gexval.com/zh-tw/info-tw/gexval-ceo-delivers-lecture-at-kindai-university-3/2024-12-20T16:37:58+09:00https://gexval.com/zh-tw/info-tw/gexval-ceo-nominated-for-the-executive-of-the-yearciteline-pharma-intelligence-awards-japan-2023-3/2024-07-19T16:42:03+09:00https://gexval.com/zh-tw/info-tw/gexval-cto-to-speak-at-ai-engineering-decoded-3/2024-09-10T16:55:52+09:00https://gexval.com/zh-tw/info-tw/announcement-of-new-chief-technology-officer-appointment-3/2024-09-11T16:44:32+09:00https://gexval.com/zh-tw/info-tw/5148/2024-09-13T08:38:05+09:00https://gexval.com/zh-tw/info-tw/gexval-selected-as-semifinalist-for-aea2024-3/2024-10-16T16:38:47+09:00https://gexval.com/zh-tw/info-tw/announcement-of-new-cfo-appointment-3/2024-09-27T21:17:39+09:00https://gexval.com/zh-tw/info-tw/gexval-showcases-innovation-speaking-and-exhibiting-at-three-premier-japanese-biotech-events-at-biojapan-2024-3/2024-10-08T21:20:51+09:00https://gexval.com/zh-tw/info-tw/gexval-selected-as-finalist-for-citeline-japan-awards-2024-in-categories-executive-of-the-year-financing-deal-of-the-year-3/2024-10-15T16:53:47+09:00https://gexval.com/zh-tw/info-tw/gexval-participates-in-bio-europe-2024%e3%80%80/2024-10-29T13:10:08+09:00https://gexval.com/zh-tw/rd-tw/gexval-selected-for-ameds-strengthening-program-for-pharmaceutical-startup-ecosystem-3/2026-03-24T17:33:52+09:00https://gexval.com/zh-tw/info-tw/fraxa-research-foundation-features-gexvals-development-program-3/2026-03-24T17:27:31+09:00https://gexval.com/zh-tw/ir-tw/gexval-raises-jpy-300m-and-partners-with-alfresa-holdings-3/2025-01-17T12:42:54+09:00https://gexval.com/zh-tw/info-tw/gexval-ceo-delivers-guest-lecture-at-keio-university-3/2025-02-04T15:57:16+09:00https://gexval.com/zh-tw/rd-tw/gexval-receives-funding-from-a-parkinsons-research-program-at-the-michael-j-fox-foundation-3/2025-02-18T11:01:24+09:00https://gexval.com/zh-tw/info-tw/our-pipeline-information-has-been-updated-3/2025-02-19T15:06:36+09:00https://gexval.com/zh-tw/info-tw/gexval-to-participate-in-bio-europe-spring-milan-2025-2/2025-02-28T14:00:15+09:00https://gexval.com/zh-tw/ir-tw/series-c-round-completed-securing-a-total-of-jpy-910-million-3/2025-03-11T15:24:07+09:00https://gexval.com/zh-tw/info-tw/data-driven-drug-discovery-platform-rephaind-to-be-presented-at-the-pharmaceutical-society-of-japan-annual-meeting-3/2025-03-17T12:55:19+09:00https://gexval.com/zh-tw/info-tw/gexval-to-present-at-bioequity-europe-2025-3/2025-05-13T10:52:04+09:00https://gexval.com/zh-tw/info-tw/gexval-to-participate-in-bio-international-convention-2025-3/2025-06-05T11:03:57+09:00https://gexval.com/zh-tw/info-tw/cto-nakayama-to-participate-in-the-7th-annual-meeting-of-the-japanese-association-for-medical-artificial-intelligence-june-27-28-2025-at-kyoto-international-conference-center-3/2025-06-19T11:13:50+09:00https://gexval.com/zh-tw/info-tw/cto-nakayama-to-participate-in-the-15th-international-workshop-on-advanced-genomics-july-2-4-2025-at-hitotsubashi-hall-3/2025-06-19T11:22:51+09:00https://gexval.com/zh-tw/info-tw/gexval-ceo-to-present-at-bio-asia-taiwan-2025-2/2025-07-14T16:51:09+09:00https://gexval.com/zh-tw/info-tw/gexval-cto-presents-at-nagoya-university-graduate-school-3/2025-09-05T11:41:22+09:00https://gexval.com/zh-tw/info-tw/gexval-ceo-to-present-at-the-workshop-on-fragile-x-syndrome-neurodevelopmental-disorders-in-the-netherlands-3/2025-09-18T16:02:32+09:00https://gexval.com/zh-tw/info-tw/gexval-gexval-senior-director-to-present-at-link-j-amed-drug-discovery-venture-event-3/2025-09-18T16:16:14+09:00https://gexval.com/zh-tw/info-tw/gexval-cto-to-present-at-iibmp2025-3/2025-09-18T18:49:02+09:00https://gexval.com/zh-tw/info-tw/gexval-to-host-australian-clinical-development-seminar-at-biojapan-2025-3/2025-10-03T11:45:00+09:00https://gexval.com/zh-tw/info-tw/gexval-to-exhibit-at-biojapan-2025-3/2025-10-03T11:36:19+09:00https://gexval.com/zh-tw/info-tw/gexval-cto-to-present-at-iibmp2025-6/2025-10-16T18:44:12+09:00https://gexval.com/zh-tw/info-tw/gexval-ceo-to-speak-at-china-healthcare-summit-2025-3/2025-10-17T15:24:05+09:00https://gexval.com/zh-tw/info-tw/gexval-to-participate-in-bio-europe-2025-3/2025-10-28T08:12:44+09:00https://gexval.com/zh-tw/info-tw/gexval-selected-as-presenting-company-at-biotech-showcase-2026-3/2026-01-07T10:16:28+09:00https://gexval.com/zh-tw/info-tw/gexval-ceo-speaks-at-university-of-tokyo-hospital-drug-dsicovery-training-program-3/2026-01-07T16:31:39+09:00https://gexval.com/zh-tw/info-tw/gexval-senior-director-speaks-at-university-of-tokyo-hospital-drug-discovery-training-program-3/2026-01-07T16:41:23+09:00https://gexval.com/zh-tw/info-tw/gexval-featured-in-biocentury-article-3/2026-01-07T17:04:16+09:00https://gexval.com/zh-tw/info-tw/gexval-invited-to-connect-to-australia-forum-in-boston-3/2026-01-13T13:51:20+09:00https://gexval.com/zh-tw/info-tw/gexval-ceo-to-present-at-ipark-kbic-meetup-2025-boston-3/2026-01-13T14:08:01+09:00https://gexval.com/zh-tw/info-tw/gexval-ceo-invited-to-present-at-australian-embassy-clinical-development-forum-3/2026-01-13T14:25:58+09:00https://gexval.com/zh-tw/info-tw/cto-nakayama-contributes-invited-article-to-experimental-medicine-japans-leading-life-science-journal-on-ai-driven-drug-discovery/2026-03-12T12:22:10+09:00https://gexval.com/zh-tw/info-tw/gexval-receives-fda-orphan-drug-designation-for-gxv-001-in-fragile-x-syndrome-3/2026-03-24T09:31:20+09:00https://gexval.com/zh-tw/info-tw/rare-disease-day-update-fraxa-features-gexvals-fraxa-dvi-completion-and-fda-orphan-drug-designation-3/2026-03-24T10:15:40+09:00https://gexval.com/zh-tw/info-tw/gexval-cto-to-present-at-the-annual-meeting-of-the-psj-3/2026-03-24T13:25:16+09:00